Newer Lung Cancer Drug Alone Beats Older Combination Therapy in Real-World Study
A large real-world study in China found that third-generation EGFR inhibitor monotherapy extended progression-free survival in advanced EGFR-mutant lung cancer ...
A large real-world study in China found that third-generation EGFR inhibitor monotherapy extended progression-free survival in advanced EGFR-mutant lung cancer ...
A new review argues that lung tumours run an integrated, adaptable metabolic network rather than isolated pathways, explaining growth under ...
New Griffith University research shows that electronic nose and gas chromatography-mass spectrometry analysis of exhaled breath can distinguish cancerous lung ...
A 1,500-patient next-generation sequencing study from Gazi University reveals EGFR and KRAS as dominant drivers in advanced NSCLC, with distinct ...
A UCLA study found that the dietary supplement calcium alpha-ketoglutarate slowed lung tumor growth in female mice while enlarging tumors ...
A new GIS-based study maps relative urban vulnerability to lung cancer across Greater Cairo, combining twenty-nine spatial indicators with a ...
A structured AGREE II appraisal of Iran's 2018 national NSCLC guideline found strong clarity of presentation but major weaknesses in ...
A controversial clinical trial has once again thrust homeopathy into the center of a scientific firestorm. In a prospective, randomized, ...
A BMC Cancer study fused a routine blood-based inflammation index with age, smoking history, and AJCC stage to build a ...
A new AI framework called BAMR-HF combines boundary-aware segmentation, radiomic–deep feature fusion, and contextual modeling to segment and classify lung ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine